
Sign up to save your podcasts
Or


Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.
By John Simboli5
77 ratings
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.

533 Listeners

3,069 Listeners

1,092 Listeners

943 Listeners

795 Listeners

124 Listeners

322 Listeners

96 Listeners

9,951 Listeners

34 Listeners

515 Listeners

146 Listeners

349 Listeners

180 Listeners

471 Listeners